Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin R Webster

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Opinion in Chemical Biology|April 10, 2021
Targeting mutant KRASDaniel A Erlanson, Kevin R Webster
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 2, 2020
A Highly Selective MNK Inhibitor Rescues Deficits Associated with Fragile X Syndrome in MiceTarjani Shukla, June Bryan de la Peña, John M Perish, et al.
JCI Insight|May 25, 2021
mRNA translation is a therapeutic vulnerability necessary for bladder epithelial transformationSujata Jana, Rucha Deo, Rowan P Hough, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
1H-Pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinases: highly potent 2,6-Difluorophenacyl analoguesRaj N Misra, Hai yun Xiao, David B Rawlins, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
1H-Pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinasesRaj N Misra, David B Rawlins, Hai-yun Xiao, et al.
Frontiers in Oncology|December 13, 2021
Zotatifin, an eIF4A-Selective Inhibitor, Blocks Tumor Growth in Receptor Tyrosine Kinase Driven TumorsAdina Gerson-Gurwitz, Nathan P Young, Vikas K Goel, et al.
Structure (London, England : 1993)|October 4, 2025
Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradationEvan J McMahon, Alexander G Cioffi, Patrick R Visperas, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Synthesis and biological activity of N-aryl-2-aminothiazoles: potent pan inhibitors of cyclin-dependent kinasesRaj N Misra, Hai-yun Xiao, David K Williams, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 22, 2018
Nociceptor Translational Profiling Reveals the Ragulator-Rag GTPase Complex as a Critical Generator of Neuropathic PainSalim Megat, Pradipta R Ray, Jamie K Moy, et al.
Nature Medicine|January 16, 2019
Translation control of the immune checkpoint in cancer and its therapeutic targetingYichen Xu, Mauro Poggio, Hyun Yong Jin, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Opinion in Chemical Biology|April 10, 2021
Targeting mutant KRASDaniel A Erlanson, Kevin R Webster
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 2, 2020
A Highly Selective MNK Inhibitor Rescues Deficits Associated with Fragile X Syndrome in MiceTarjani Shukla, June Bryan de la Peña, John M Perish, et al.
JCI Insight|May 25, 2021
mRNA translation is a therapeutic vulnerability necessary for bladder epithelial transformationSujata Jana, Rucha Deo, Rowan P Hough, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
1H-Pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinases: highly potent 2,6-Difluorophenacyl analoguesRaj N Misra, Hai yun Xiao, David B Rawlins, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
1H-Pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinasesRaj N Misra, David B Rawlins, Hai-yun Xiao, et al.
Frontiers in Oncology|December 13, 2021
Zotatifin, an eIF4A-Selective Inhibitor, Blocks Tumor Growth in Receptor Tyrosine Kinase Driven TumorsAdina Gerson-Gurwitz, Nathan P Young, Vikas K Goel, et al.
Structure (London, England : 1993)|October 4, 2025
Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradationEvan J McMahon, Alexander G Cioffi, Patrick R Visperas, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Synthesis and biological activity of N-aryl-2-aminothiazoles: potent pan inhibitors of cyclin-dependent kinasesRaj N Misra, Hai-yun Xiao, David K Williams, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 22, 2018
Nociceptor Translational Profiling Reveals the Ragulator-Rag GTPase Complex as a Critical Generator of Neuropathic PainSalim Megat, Pradipta R Ray, Jamie K Moy, et al.
Nature Medicine|January 16, 2019
Translation control of the immune checkpoint in cancer and its therapeutic targetingYichen Xu, Mauro Poggio, Hyun Yong Jin, et al.
Pageof 2